JournalsHub
.online
Find My Journal
AC

Allen Lee Cohn

Rocky Mountain Cancer Centers US

231
Publications
15,104
Citations
48
H-Index
104
i10-Index
5.48
2yr Mean Cite
-
Cite/Paper
Data combined from OpenAlex + Semantic Scholar. OA = OpenAlex S2 = Semantic Scholar
Verify on Google Scholar

Publication & Citation Trends

Most Cited Works

Pembrolizumab in patients with advanced hepatocellular carcinoma previously treated with sorafenib (KEYNOTE-224): a non-randomised, open-label phase 2 trial
Andrew X. Zhu, Richard S. Finn, Julien Edeline, Stéphane Cattan, Sadahisa Ogasawara +54 more
The Lancet Oncology 2018
2,503
Sensitive and specific multi-cancer detection and localization using methylation signatures in cell-free DNA OA
M.C. Liu, Geoffrey R. Oxnard, Eric A. Klein, Charles Swanton, Michael V. Seiden +95 more
Annals of Oncology 2020
1,447
Ramucirumab versus placebo in combination with second-line FOLFIRI in patients with metastatic colorectal carcinoma that progressed during or after first-line therapy with bevacizumab, oxaliplatin, and a fluoropyrimidine (RAISE): a randomised, double-blind, multicentre, phase 3 study
Josep Tabernero, Takayuki Yoshino, Allen Lee Cohn, Radka Obermannová, G. Bodoky +14 more
The Lancet Oncology 2015
943
Clinical validation of a targeted methylation-based multi-cancer early detection test using an independent validation set OA
Eric A. Klein, Donald Richards, Allen Lee Cohn, Meghna Tummala, Rosanna L. Lapham +10 more
Annals of Oncology 2021
900
A Randomized Phase IIIB Trial of Chemotherapy, Bevacizumab, and Panitumumab Compared With Chemotherapy and Bevacizumab Alone for Metastatic Colorectal Cancer OA
J. Randolph Hecht, Edith P. Mitchell, Tarek Chidiac, Carroll Scroggin, Christopher Hagenstad +8 more
Journal of Clinical Oncology 2008
851

Publications

229 total

Phase II study of tinengotinib in advanced cholangiocarcinoma: Analysis of molecular response and resistance mechanisms.

Angela Lamarca, M. Javle, C. Fountzilas, Chih-Yi Liao, Meredith S. Pelster - Journal of Clinical Oncology, 2026
Cited by 0 Semantic Scholar

Use of yttrium-90 radioembolization to control liver metastases in pancreatic acinar cell carcinoma and pancreatoblastoma: Two case reports

Nebojsa Skorupan, D. Sperling, Charles Nutting, Markku Miettinen, A. Cohn - World Journal of Gastroenterology, 2026
Cited by 0 Semantic Scholar

Prognostic significance of blood-based multi-cancer detection in circulating tumor DNA (ctDNA): 5-year outcomes analysis.

Robert Charles Swanton, A. Cohn, Matthew Margolis, Earl Hubbell, Stephannie Shih - Journal of Clinical Oncology, 2025
Cited by 0 Semantic Scholar

POD1UM-303/INTERAACT2 subgroup analyses and impact of delayed retifanlimab treatment on outcomes in patients with squamous cell carcinoma of the anal canal (SCAC).

M. Fakih, Rebecca Muirhead, A. Scott, Mohit Narang, A. Cohn - Journal of Clinical Oncology, 2025
Cited by 0 Semantic Scholar

Tinengotinib for adults with advanced or metastatic cholangiocarcinoma: a multicentre, open-label, phase 2 trial.

M. Javle, C. Fountzilas, Chih-Yi Liao, Meredith Pelster, Daneng Li - The Lancet Gastroenterology and Hepatology, 2025
Cited by 5 Semantic Scholar

Evaluation of cell-free DNA approaches for multi-cancer early detection PDF

Arash Jamshidi, Minetta C. Liu, Eric A. Klein, Oliver Venn, Earl Hubbell et al. - Cancer Cell, 2022
Cited by 293 OpenAlex

Clinical validation of a targeted methylation-based multi-cancer early detection test using an independent validation set PDF

Eric A. Klein, Donald Richards, Allen Lee Cohn, Meghna Tummala, Rosanna L. Lapham et al. - Annals of Oncology, 2021
Cited by 900 OpenAlex

Lenvatinib plus pembrolizumab in patients with either treatment-naive or previously treated metastatic renal cell carcinoma (Study 111/KEYNOTE-146): a phase 1b/2 study PDF

Chung‐Han Lee, Amishi Y. Shah, Drew Rasco, Arpit Rao, Matthew H. Taylor et al. - The Lancet Oncology, 2021
Cited by 179 OpenAlex

Sensitive and specific multi-cancer detection and localization using methylation signatures in cell-free DNA PDF

M.C. Liu, Geoffrey R. Oxnard, Eric A. Klein, Charles Swanton, Michael V. Seiden et al. - Annals of Oncology, 2020
Cited by 1,447 OpenAlex

Lenvatinib Plus Pembrolizumab in Patients With Advanced Endometrial Cancer PDF

Vicky Makker, Matthew H. Taylor, Carol Aghajanian, Ana Oaknin, James W. Mier et al. - Journal of Clinical Oncology, 2020
Cited by 516 OpenAlex

Research Topics

Colorectal Cancer Treatments and Studies (95) Cancer Treatment and Pharmacology (58) Lung Cancer Treatments and Mutations (51) Gastric Cancer Management and Outcomes (37) Hepatocellular Carcinoma Treatment and Prognosis (30)

Frequent Co-Authors

ER
Eric A. Klein
4 joint publications
CH
Charles Swanton
4 joint publications
MI
Michael V. Seiden
4 joint publications
NA
Nathan Hunkapiller
3 joint publications
AR
Arash Jamshidi
3 joint publications
MA
Matthew H. Taylor
3 joint publications

Affiliations

University of Southern California
US 2012 - 2012
National Institutes of Health
US 2012 - 2012
McKesson (United States)
US 2019 - 2013
Abbott Northwestern Hospital
US 2006 - 2006
Amgen (United States)
US 2012 - 2009

External Profiles

OpenAlex Profile Semantic Scholar Profile Google Scholar

Share Profile

Back to Researchers
Comparison Shortlist
0 journals
Est. APC Budget: $0
Compare Now